What Will Happen When Rebates Go Away? Look At Authorized Generics
Recent launches by Lilly, Amgen and Gilead suggest list prices may decrease with the HHS proposal to disrupt the rebate system, but not as low as current net prices after rebates, according to pharmacy benefit experts.
You may also be interested in...
Plan envisions manufacturers, acting under FDA guidance, will import their own drugs and introduce them in the US under a new national drug code at a lower list price.
HHS downplays latest attempt to predict “complex behavior changes to a broken system.”
Lilly will launch an authorized generic version of Humalog at a 50% discount to the brand to assist patients without insurance or a high deductible, who don't benefit from rebates.